Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing™, a new biotechnology designed to offer scientists and doctors the…
Location: United States, Massachusetts, Cambridge
Employees: 201-500
Total raised: $530M
Founded date: 2018
Investors 7
Funding Rounds 2
| Date | Series | Amount | Investors |
| 19.04.2022 | Series C | $300M | - |
| 12.01.2021 | Series B | $230M | - |
Mentions in press and media 16
| Date | Title | Description |
| 07.05.2025 | Flagship Pioneering, the National University of Singapore, National University Hospital and the National University Health System Announce Collaboration to Advance Biotech Research & Development | Collaboration Aims to Expand Globally Connected Scientific Dialogue and Accelerate Innovation in Human Health and Sustainability SINGAPORE, May 7, 2025 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, the Yong Loo Li... |
| 19.12.2024 | Alira Health's Bold Leap: $100 Million Growth Debt Facility Secured | Alira Health is on the rise. The Framingham, MA-based healthcare consulting and technology firm has secured a significant growth debt facility of up to $100 million from Symbiotic Capital. This infusion of capital is not just a financial bo... |
| 18.12.2024 | Tessera Therapeutics Receives Investment From Bill & Melinda Gates Foundation | Tessera Therapeutics, a Somerville, MA-based biotechnology company providing a new approach to genome engineering through the development of its Gene Writing™ and delivery platforms, received an investment from Bill & Melinda Gates Foun... |
| 18.12.2024 | Alira Health Secures Up to $100M Growth Debt Facility from Symbiotic Capital | Alira Health, a Framingham, MA-based healthcare consulting and technology firm, raised up to $100M in growth debt facility from Symbiotic Capital. The company intends to use the funds to drive its strategic growth, enhance its innovative te... |
| 03.10.2024 | A*STAR and Flagship Pioneering Announce Partnership to Spur Biotech Innovation in Singapore | Organizations Plan to Jointly Advance Breakthrough Solutions in Human Health and Sustainability, Drive Research Collaboration, Entrepreneurship and Accelerate Talent Development SINGAPORE, Oct. 3, 2024 /PRNewswire/ -- The Agency for Science... |
| 28.08.2024 | Flagship Pioneering and Quotient Therapeutics Announce Agreement to Identify Potential Novel Targets for the Treatment of Cardiovascular and Renal Diseases under Strategic Partnership with Pfizer | Collaboration leverages Quotient's platform to identify somatic mutations in genes that modify the progression of cardiovascular and renal diseases Quotient and Pioneering Medicines, Flagship's in-house drug development unit, will jointly c... |
| 06.08.2024 | Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner | Former White House Top Health Security Official to Lead Flagship's Preemptive Health and Medicine Initiative CAMBRIDGE, Mass., Aug. 6, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced that global... |
| 10.07.2024 | Flagship Pioneering Raises $3.6 Billion to Fuel Breakthrough Innovations that Transform Human Health and Sustainability | Record Year with Key Partnerships, Global Expansion and Expanded Top Talent CAMBRIDGE, Mass., July 10, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced it has expanded its capital base by $3.6 bi... |
| 20.04.2022 | Venture capitalists just keep plowing billions into crypto startups | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Oh hey. Declan Harty here today, filling in for Jessica. Today we’re diving into VC funding in wh... |
| 19.04.2022 | Tessera Therapeutics Raises Over $300M in Series C Financing | Tessera Therapeutics, a Somerville, MA-based biotechnology company, raised over $300M in Series C funding. Investors included Abu Dhabi Investment Authority (ADIA), Alaska Permanent Fund Corporation, Altitude Life Science Ventures, ARTIS Ve... |
Show more